# Pramipexole Conversion to Ropinirole Controlled Release (CR)

> **NCT00275275** · PHASE3 · COMPLETED · sponsor: **Rajesh Pahwa, MD** · enrollment: 61 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Requip PR
- **DRUG:** Mirapex

## Key facts

- **NCT ID:** NCT00275275
- **Lead sponsor:** Rajesh Pahwa, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2012-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00275275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00275275, "Pramipexole Conversion to Ropinirole Controlled Release (CR)". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00275275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*